Nephros, Inc. splits its revenue into 2 lines in its filings. The largest line in Q3 of fiscal 2026, the quarter ended Sep 30, 2026 was Product at $5.4 million, 97% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Sep 30, 2026
|
Q3 FY2026
Sep 30, 2026
|
Q2 FY2026
Jun 30, 2026
|
Q1 FY2026
Mar 31, 2026
|
Q4 FY2025
Dec 31, 2025
|
Q3 FY2025
Sep 30, 2025
|
Q2 FY2025
Jun 30, 2025
|
Q1 FY2025
Mar 31, 2025
|
Q4 FY2024
Dec 31, 2024
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
22
|
6
|
6
|
5
|
5
|
5
|
4
|
5
|
4
|
| Product |
21
+19.1%
share 96.4%
|
5
+18.2%
share 96.6%
|
6
+32.2%
share 94.7%
|
5
+7.1%
share 96.7%
|
5
+20.1%
share 97.7%
|
5
share 96.5%
|
4
share 97.6%
|
5
share 96.5%
|
4
share 99.5%
|
| Service Royalty And Other Revenues |
1
+68.2%
share 3.6%
|
0
+13.7%
share 3.4%
|
0
+192.6%
share 5.3%
|
0
+0.6%
share 3.3%
|
0
+414.3%
share 2.3%
|
0
share 3.5%
|
0
share 2.4%
|
0
share 3.5%
|
0
share 0.5%
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- NEPH (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South Orange, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1196298
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.